Top compounds associated with response to LIX1L


Feature Type Standardized
Nominal ANOVA
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.13 0.0009
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.001
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.13 0.001
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.14 0.001
mRNA niclosamide CTRPv2 pan-cancer AAC 0.14 0.001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.001
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.14 0.001
mRNA CP724714 GDSC1000 pan-cancer AAC -0.12 0.002
mRNA ouabain CTRPv2 pan-cancer AAC 0.13 0.002
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.12 0.002
Download CSV